Notably, in mice lacking adiponectin, the beneficial effects of FGF21, such as alleviating obesity-associated insulin resistance, hyperglycemia, hyperlipidemia, and hepatic steatosis, are diminished [51]. The gene discussed is ADIPOQ; the disease is obesity disorder.